Annalisa Chiarenza, MD

UOC Ematologia, AOU Policlinico G.Rodolico-San Marco, Italy

N/A

Poster(s):

• 1122 - Integrative epi(genome) analysis of CD49d bimodal expression reveals epigenetically driven phenotypic transitions in CLL

• 1709 - Impact of Dose Intensity of Ibrutinib on Clinical Outcomes of CLL Patients: Analysis of the EVIdeNCE Study